1. Home
  2. LZM vs GOSS Comparison

LZM vs GOSS Comparison

Compare LZM & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LZM
  • GOSS
  • Stock Information
  • Founded
  • LZM 2021
  • GOSS 2015
  • Country
  • LZM Isle of Man
  • GOSS United States
  • Employees
  • LZM N/A
  • GOSS N/A
  • Industry
  • LZM Metal Mining
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • LZM Basic Materials
  • GOSS Health Care
  • Exchange
  • LZM Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • LZM 371.9M
  • GOSS 347.8M
  • IPO Year
  • LZM N/A
  • GOSS 2019
  • Fundamental
  • Price
  • LZM $4.53
  • GOSS $2.47
  • Analyst Decision
  • LZM Strong Buy
  • GOSS Strong Buy
  • Analyst Count
  • LZM 1
  • GOSS 4
  • Target Price
  • LZM $14.00
  • GOSS $8.50
  • AVG Volume (30 Days)
  • LZM 89.0K
  • GOSS 3.1M
  • Earning Date
  • LZM 08-11-2025
  • GOSS 08-05-2025
  • Dividend Yield
  • LZM N/A
  • GOSS N/A
  • EPS Growth
  • LZM N/A
  • GOSS N/A
  • EPS
  • LZM N/A
  • GOSS N/A
  • Revenue
  • LZM $416,323.00
  • GOSS $40,237,000.00
  • Revenue This Year
  • LZM $611.56
  • GOSS N/A
  • Revenue Next Year
  • LZM $344.44
  • GOSS $30.65
  • P/E Ratio
  • LZM N/A
  • GOSS N/A
  • Revenue Growth
  • LZM N/A
  • GOSS N/A
  • 52 Week Low
  • LZM $2.90
  • GOSS $0.66
  • 52 Week High
  • LZM $7.29
  • GOSS $2.65
  • Technical
  • Relative Strength Index (RSI)
  • LZM 46.66
  • GOSS 68.08
  • Support Level
  • LZM $4.21
  • GOSS $2.38
  • Resistance Level
  • LZM $4.74
  • GOSS $2.65
  • Average True Range (ATR)
  • LZM 0.20
  • GOSS 0.15
  • MACD
  • LZM -0.01
  • GOSS 0.03
  • Stochastic Oscillator
  • LZM 25.00
  • GOSS 76.67

About LZM Lifezone Metals Limited

Lifezone Metals Ltd seeks to support the clean energy transition through the licensing of Hydromet Technology as an alternative to smelting and metals refining and to become an emerging supplier of responsibly sourced, lower-carbon and lower-sulfur dioxide emission metals to the battery, EV, and hydrogen markets modern pre-development exploration-stage metals company. Its business comprises three segments: Metals extraction and refining for developing and operating a vertically integrated base metal operation in the northwest region of Tanzania and Intellectual property licensing comprises patents residing with and managed by the subsidiary and corporate.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: